Study: Patients more likely to stay on Lipitor

Drugmaker Pfizer is reporting that patients who take the cholesterol-lowering drug Lipitor are more likely to stay on the medication than those given the generic form of Zocor. This finding is based on a study of 186,000 patients in a large U.S. managed healthcare claims database. Experts at Pfizer, which makes Lipitor, say this finding is significant both because stopping statins has been linked with an increase in heart attacks and strokes, and because there is increasing pressure for doctors to switch patients to cheaper, generic drugs.

(Medical News Today) UPDATED 07/09/2008
Click here to read the full story
Conditions: | atherosclerosis - 406 Articles | heart disease - 622 Articles | high cholesterol - 483 Articles | stroke - 502 Articles Treatments: | Lipitor - 169 Articles | Zocor - 150 Articles
Helpful?
YesNo 




Navigation

Member Picks
Three vitamin supplements reflux sufferers may need
View Full Story
Chronic pain harms the brain
View Full Story
Research your meds on the Treatments tab
View Full Story
Caffeine could spell trouble for diabetics
View Full Story